Incidence of deep venous thrombosis in COVID-19 hospitalized patients during the first peak of the Italian outbreak.

Domenico BaccellieriLuca BertoglioLuca ApruzziVincenzo ArditaArmando D'AngeloMatteo BossiEnrico RinaldiVictor BilmanStefania CalvisiAntonella CastagnaLaura GalliGiovanni LandoniGermano MelissanoPatrizia Rovere QueriniMoreno TresoldiFrancesco De CobelliAlberto ZangrilloFabio CiceriRoberto Chiesa

Published in: Phlebology (2020)

Despite LMWH prophylaxis or full anticoagulant therapy, the incidence of DVT, mainly asymptomatic, in hospitalized COVID-19 patients was 14.5%. Further research should focus on the appropriate antithrombotic therapy for COVID-19 patients.

Keyphrases

sars cov
risk factors
atrial fibrillation
coronavirus disease
respiratory syndrome coronavirus
venous thromboembolism
stem cells
mesenchymal stem cells